Depth over breadth: Piramal Consumer Healthcare takes a leaf out of the modern FMCG playbook

The company’s latest initiative unifies its women’s healthcare portfolio under a single identity: i-choose. This line includes menstrual panties, menstrual cups and pregnancy test kits. The i-pill emergency contraceptive, the star product in its segment, remains on the National Pharmaceutical Pricing Authority’s (NPPA) price-limiting list of essential medicines. The company said that this price control mechanism, implemented in March 2024, has impacted its FY25 revenues.